Matches in Wikidata for { <http://www.wikidata.org/entity/Q92207924> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q92207924 description "clinical trial" @default.
- Q92207924 description "ensayo clínico" @default.
- Q92207924 description "ensayu clínicu" @default.
- Q92207924 description "klinisch onderzoek" @default.
- Q92207924 description "клінічне випробування" @default.
- Q92207924 name "Testing the Addition of Copanlisib to Eribulin for the Treatment of Advanced-Stage Triple Negative Breast Cancer" @default.
- Q92207924 name "Testing the Addition of Copanlisib to Eribulin for the Treatment of Advanced-Stage Triple Negative Breast Cancer" @default.
- Q92207924 type Item @default.
- Q92207924 label "Testing the Addition of Copanlisib to Eribulin for the Treatment of Advanced-Stage Triple Negative Breast Cancer" @default.
- Q92207924 label "Testing the Addition of Copanlisib to Eribulin for the Treatment of Advanced-Stage Triple Negative Breast Cancer" @default.
- Q92207924 prefLabel "Testing the Addition of Copanlisib to Eribulin for the Treatment of Advanced-Stage Triple Negative Breast Cancer" @default.
- Q92207924 prefLabel "Testing the Addition of Copanlisib to Eribulin for the Treatment of Advanced-Stage Triple Negative Breast Cancer" @default.
- Q92207924 P1050 Q92207924-FA8EA00A-4B71-43F5-BEC1-39A041E07A0D @default.
- Q92207924 P1132 Q92207924-039B1034-44A9-47F7-A4B5-775F93A4FDE1 @default.
- Q92207924 P1476 Q92207924-62234D0C-8448-484F-B7BB-D70E774AE41C @default.
- Q92207924 P2899 Q92207924-55FCA982-7BC5-4954-8EF4-45E84F7B20C1 @default.
- Q92207924 P3098 Q92207924-3C393BC5-3ECA-4501-B274-3EEA4E7D59EC @default.
- Q92207924 P31 Q92207924-F33C9EA5-6AA7-4DB3-88A2-8D73EE2F15F8 @default.
- Q92207924 P4844 Q92207924-66F7558D-C2D8-4F96-B8C7-898B0854C8E6 @default.
- Q92207924 P580 Q92207924-CC165BDD-4EF0-4C99-96B9-301099611E07 @default.
- Q92207924 P582 Q92207924-51984095-2949-4828-A264-0A532B59369A @default.
- Q92207924 P6099 Q92207924-3C7CE427-CD1D-41C2-9735-719CC6403EAD @default.
- Q92207924 P6099 Q92207924-8B221309-0CB6-4983-BF74-6090CDFC9CFC @default.
- Q92207924 P8363 Q92207924-BD893764-D898-4FC0-8A8A-165F7E6E56F1 @default.
- Q92207924 P859 Q92207924-5239C4CA-0B61-436E-B39D-15395A77279B @default.
- Q92207924 P1050 Q33525 @default.
- Q92207924 P1132 "+106" @default.
- Q92207924 P1476 "A Phase I/II Trial Evaluating the Safety and Efficacy of Eribulin in Combination With Copanlisib in Patients With Metastatic Triple Negative Breast Cancer" @default.
- Q92207924 P2899 "+18" @default.
- Q92207924 P3098 "NCT04345913" @default.
- Q92207924 P31 Q30612 @default.
- Q92207924 P4844 Q4993812 @default.
- Q92207924 P580 "2020-10-16T00:00:00Z" @default.
- Q92207924 P582 "2021-03-16T00:00:00Z" @default.
- Q92207924 P6099 Q42824440 @default.
- Q92207924 P6099 Q5452194 @default.
- Q92207924 P8363 Q78089383 @default.
- Q92207924 P859 Q664846 @default.